Aktie A144DE IOL CHEMICALS AND PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen IOL Chemicals and Pharmaceuticals Limited NSE India S.E.

Aktien

A144DE

INE485C01011

IOLCP

Verzögert NSE India S.E.
Andere Börsenplätze
 09:48:38 26.06.2024 		% 5 Tage % 1. Jan.
410,2 INR +1,35 % Intraday Chart für IOL Chemicals and Pharmaceuticals Limited -0,51 % -11,42 %
16.05. Transcript : IOL Chemicals and Pharmaceuticals Limited, Q4 2024 Earnings Call, May 16, 2024
19.03. IOL Chemicals erhält von der brasilianischen Gesundheitsbehörde nach der Inspektion von Einheiten null Beobachtungen MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units
IOL Chemicals Gets Nod to Export Diabetes Drug to China
IOL Chemicals and Pharmaceuticals Limited Announces CDE, China Approved Metformin Hydrochloride
IOL Chemicals and Pharmaceuticals Limited Approves Closing of M/S Iol Global Limited, Uk, Wholly Owned Subsidiary of the Company
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Financial Year 2023-24
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CARE Keeps A+ Rating on IOL Chemicals' Long-term Bank Financing; Outlook Stable
IOL Chemicals Opens New Acetic Anhydride Facility
IOL Chemicals Granted New Patent in India
IOL Chemicals Gets European Drug Regulator's Approval to Export Paracetamol
IOL Chemicals and Pharmaceuticals Receives Cep for Paracetamol to Export in European Market
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
IOL Chemicals Appoints CEO
IOL Chemicals and Pharmaceuticals Appoints Vikas Vij as CEO
IOL Chemicals and Pharmaceuticals Limited Announces Resignation of Sanjay Chaturvedi as CEO
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Fiscal Year 2023, Payable Before 8 March 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
IOL Chemicals & Pharmaceuticals Forms New Unit in UK
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A144DE Aktie
  4. A144DE Aktie
  5. Nachrichten IOL Chemicals and Pharmaceuticals Limited
  6. Andere Sprachen